# GSK: New Data Shows RSV Vaccine's Potential In Adults Aged 50 To 59 At Increased Risk For RSV-LRTD
**Stock News**

**2023-10-25 06:43**

**https://www.ainvest.com/news/gsk-new-data-shows-rsv-vaccine-s-potential-in-adults-aged-50-to-59-at-increased-risk-for-rsv-lrtd-23101000909269f771ccca96/**

GSK: New Data Shows RSV Vaccine's Potential In Adults Aged 50 To 59 At Increased Risk For RSV-LRTD